2,801
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagA+Helicobacter pylori

, , , , &
Pages 92-98 | Received 02 Jun 2008, Accepted 17 Jun 2008, Published online: 01 Jan 2009

References

  • Bhattacharyya A, Pathak S, Datta S, Chattopadhyay S, Basu J, Kundu M (2000): Mitogen-activated protein kinases and nuclear factor-κB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem J 368(Pt 1): 121–129.
  • Bliss CM Jr, Golenbock DT, Keates S, Linevsky JK, Kelly CP (1998): Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 66: 5357–5363.
  • Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H (1999): Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 60: 210–215.
  • Bode AM, Wei-Ya Ma, Surh YJ, Dong ZG (2001): Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 61: 850–853.
  • Censini S, Lange C, Xiang Z (1996): Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease associated virulence factors. Proc Natl Acad Sci U S A 93: 14648–14653.
  • Ernst PB, Crowe SE, Reyes V (1997): How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 113: S35–S42.
  • Figueiredo C, Machado JC, Pharoah P (2002): Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94: 1680–1687.
  • Forman D, Graham DY (1994): Impact of Helicobacter pylori on society – role for a strategy of ‘search and eradicate’. Aliment Pharmacol Ther 19(Suppl 1): 17–21.
  • Fujiwara Y, Higuchi K, Fukuda T, Watanabe T, Tominaga K, Arakawa T (2001): Inhibitory effect of sofalcone on tumor necrosis factor-α and interleukin-1β production in human monocytes stimulated by Helicobacter pylori water extract. Drugs Exp Clin Res 27: 103–106.
  • Huang C, Ma WY, Dong Z (1996): Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol Cell Biol 16: 6427–6435.
  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994): Schistomsomes, Liver Flukes and Helicobacter pylori. Infections with Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Lyon, International Agency for Research on Cancer, pp 177–201.
  • Ikeno T, Ota H, Sugiyama A (1999): Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol 154: 951–960.
  • Israel DA, Salama N, Arnold CN, Peek RJr (2001): Helicobacter pylori-strain specific differences in genetic content, identified by microarray, influence host inflammatory response. J. Clin Invest 107: 611–620.
  • Katiyar S K, Agarwal R, Mukhtar H (1996): Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res 56: 1023–1030.
  • Kozol RA, Domanowski R, Jaszewski R, Czanko B, McCurdy M, Prasad B, Fromm R (1991): Neutrophil chemotaxis in gastric mucosa. A signal-to-response comparison. Dig Dis Sci 36: 1277–1280.
  • Lee E, Surh YJ (1998): Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol, and [6]-paradol. Cancer Lett 134: 163–168.
  • Lee E, Park KK, Lee JM, Chun KS, Kang J Y, Lee SS, Surh YJ (1998): Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae). Carcinogenesis (Lond) 19: 1377–1381.
  • Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A (2003): Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of CagA+ strains of Helicobacter pylori. Anticancer Res 23: 3699–3702.
  • NCCLS (2008) Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement. NCCLS document M100-S9. National Committee for Clinical Laboratory Standards, Wayne, PA, pp. 120–126.
  • Park EJ, Pezzuto JM (2002): Botanicals in cancer chemoprevention. Cancer Metastasis Rev 21: 231–255.
  • Sakai T, Fukui H, Franceschi F, Penland R, Sepulveda AR, Fujimori T, Terano A, Genta RM, Graham DY, Yamaoka Y (2003): Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Digest Dis Sci 48: 2139–2146.
  • Scheiman JM, Cutler AF (1999): Helicobacter pylori and gastric cancer. Am J Med 106: 222–226.
  • Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J (2001): Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 96: 3406–3410.
  • Surh YJ (2002): Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem Toxicol 40: 1091–1097.
  • Suzuki M, Miura S, Suematsu M (1993): Helicobacter pylori elicits gastric mucosal cell damage associated with neutrophil-derived toxic oxidants. Eur J Gastroenterol Hepatol 5: S35–S39.
  • Takahashi S, Fujita T, Yamamoto A (2000): Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am J Physiol Gastrointest Liver Physiol 279: G791–G798.
  • Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD, Duke CC (2001): Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem 29: 156–163.
  • Tsuji S, Kawai N, Tsujii M, Kawano S, Hori M (2003): Inflammation-related promotion of gastrointestinal carcinogenesis – a perigenetic pathway. Aliment Pharmacol Ther 18(Suppl 1): 82–89.
  • Wallace JL (1991): Possible mechanisms and mediators of gastritis associated with Helicobacter pylori infection. Scand J Gastroenterol 187: 65–70.
  • Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999): Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci U S A 96: 7563–7568.
  • Welker P, Lippert U, Nurnberg W, Kruger-Krasagakes S, Moller A, Czarnetzki BM (1996): Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int Arch Allergy Immunol 109: 110–115.
  • Yao YL, Zhang WD, Xu B (2002): Long-term infection with Helicobacter pylori in Mongolian gerbils. Chin J Digest Dis 3: 115–119.
  • Yoshimi N, Wang A, Morishita Y, Tanaka T, Sugie S, Kawai K, Yamahara J, Mori H (1992): Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn J Cancer Res 83: 1273–1278.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.